NCT01972854 - Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2017

Conditions

Keratoconus

Interventions

DRUG

riboflavin solution

0.12% riboflavin ophthalmic solution

DRUG

placebo solution

0.0% riboflavin ophthalmic solution

DEVICE

KXL System

30mW/cm2

Trial Locations (11)

UPMC Eye Center, Pittsburgh

See Clearly Vision, McLean

Price Vision Group, Indianapolis

Vance Thompson Vision, Sioux Falls

Durrie Vision, Overland Park

Focal Point Vision, San Antonio

Hoopes Vision, Draper

Gordon -Weiss Vision Institute, San Diego

UC Irvine Department of Ophthalmology, Irvine

Ophthalmic Consultants of Boston, Waltham

Hersh Vision Group, Teaneck